Results 71 to 80 of about 724,601 (205)

Personalized antifungal susceptibility testing [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 1999
CONTI, Stefania   +6 more
openaire   +5 more sources

Candida antifungal drug resistance in sub-Saharan African populations: A systematic review [version 2; referees: 2 approved]

open access: yesF1000Research, 2017
Background: Candida infections are responsible for increased morbidity and mortality rates in at-risk patients, especially in developing countries where there is limited access to antifungal drugs and a high burden of HIV co-infection.
Charlene Wilma Joyce Africa   +1 more
doaj   +1 more source

Candida antifungal drug resistance in sub-Saharan African populations: A systematic review [version 1; referees: 2 approved]

open access: yesF1000Research, 2016
Background: Candida infections are responsible for increased morbidity and mortality rates in at-risk patients, especially in developing countries where there is limited access to antifungal drugs and a high burden of HIV co-infection.
Charlene Wilma Joyce Africa   +1 more
doaj   +1 more source

Antifungal drug susceptibility of Candida albicans

open access: yesEast African Medical Journal, 2002
To determine the susceptibility of clinical isolates of Candida albicans and to establish the minimum inhibitory concentrations (MIC) to commonly used antifungal drugs.Laboratory based experiment.Mbagathi District Hospital, Nairobi, Kenya.Candida albicans isolated between 1998 and 2000 from the sputa of HIV/AIDS patients and throat swabs of children ...
Bii, C. C.   +3 more
openaire   +4 more sources

In vitro Antifungal Susceptibility Profile of Clinical Cladophialophora boppii in Malaysia [PDF]

open access: yes
Xue Ting Tan,1 Nurin Nazirah Mokhtar,1 Murnihayati Hassan,1 Min Moon Tang2 1Bacteriology Unit, Infectious Diseases Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, Selangor, Malaysia;
Hassan M, Tang MM, Tan XT, Mokhtar NN
core  

Antifungal susceptibility of C. krusei isolates (n = 18) and reference strain C. krusei ATCC 6258 to conventional antifungal agents and LMM11.

open access: yes, 2020
Antifungal susceptibility of C. krusei isolates (n = 18) and reference strain C. krusei ATCC 6258 to conventional antifungal agents and LMM11.
Patrícia de Souza Bonfim de Mendonça (8299317)   +9 more
core   +1 more source

Black aspergilli: A remaining challenge in fungal taxonomy?

open access: yes, 2018
<p>Aspergillus section Nigri is a taxonomically difficult but medically and economically important group. In this study, an update of the taxonomy of A. section Nigri strains within the BCCM/IHEM collection has been conducted.
D. Stubbe   +5 more
core   +1 more source

Neosartorya udagawae pulmonary infection requiring a surgical treatment in a paediatric haematopoietic progenitor cell recipient

open access: yesMedical Mycology Case Reports
Neosartorya udagawae is a known cause of fungal infection in humans and animals. It is found to be more refractory to antifungal treatment in comparison to other Aspergillus species.
Olga S. Tatarinova   +5 more
doaj   +1 more source

Distribution and Antifungal Susceptibility of Candida Species Isolated from Blood Cultures

open access: yesCerrahpaşa Medical Journal
Objective: Candidemia is defined as the isolation of Candida species from blood and is an infection with high mortality and morbidity. Although Candida albicans is the most common causative agent of candidemia in blood cultures, the detection rate of ...
Fadime Yılmaz Yücel, Hülya Duran
doaj   +1 more source

Antifungal susceptibility of the Cryptococcus gattii molecular type VGIII isolates by serotype.

open access: yes, 2016
Antifungal susceptibility of the Cryptococcus gattii molecular type VGIII isolates by serotype.
Laura Rocío Castañón-Olivares (3141750)   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy